Purchase Order 36C24225P1342
Award Date
8/8/25
Potential Completion Date
9/30/25
Potential Value
$17K
Federal Agency
Veterans Integrated Service Network 2
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $14,221.32 firm fixed price purchase order to Accredo Health Group, Inc. for the delivery of treprostinil 0.6mg/ml solution for inhalation. Performance will take place in Bartlett, Tennessee over the period of October 5, 2023 through October 31, 2023. The award was made using the Federal Supply Schedule, which provides standard drugs, pharmaceuticals, and medical supplies to meet...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical Tyvaso. The total ceiling value of the contract is $81,342.18, with a period of performance through September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
This is a $93,341.96 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the specialty pharmaceutical Tyvaso, which is used to treat pulmonary arterial hypertension. This contract is part of Accredo Health Group's ongoing work supporting the VA's Veterans Integrated Service Network (VISN) 21 with the distribution of specialty medications. The...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract, valued at $94,899.21, is for the delivery of the drug Tyvaso, which is used to treat pulmonary arterial hypertension. The contract is not associated with a larger contract vehicle and does not have a set-aside designation. Accredo Health Group, Inc. is the prime contractor and there are no major...
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA), to Accredo Health Group, Inc., a for-profit pharmaceutical company based in Memphis, Tennessee. The contract is for the provision of DUOPA medication, an emergency pharmaceutical product, with a ceiling value of $10,122.32 and a period of performance ending on September 30, 2025. The contract does not utilize any set-aside...
This federal contract award is for the purchase of specialty medications by the U.S. Department of Veterans Affairs (VA) from Accredo Health Group, Inc., a specialty pharmacy services provider. The contract award, valued at $2,603.79, is for the delivery of specific high-value medications to VA medical centers and facilities nationwide, supporting the Veterans Health Administration's (VHA) treatment programs. The contract is a firm fixed-price purchase order with no set-aside designation....
This is a federal purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a specialty pharmacy services provider, for the supply of TYVASCO MEDICATION 0.6MG REFILL KITS. The $14,693.72 firm fixed-price contract has an ultimate completion date of October 9, 2024. Accredo, a subsidiary of Express Scripts, is a prime contractor that specializes in distributing complex and costly drugs used to treat chronic conditions, particularly in support of the VA's...
Accredo Health Group, Inc. was awarded a firm fixed price purchase order without set aside designation from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The order is for the delivery of UPTRAVI to locations in Palo Alto, California, with a potential value of $13,985.29 and an completion date of April 20, 2023. As a prime contractor, Accredo Health Group will utilize its specialty pharmacy services and distribution network to directly...